Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors.

Gusach A, Luginina A, Marin E, Brouillette RL, Besserer-Offroy É, Longpré JM, Ishchenko A, Popov P, Patel N, Fujimoto T, Maruyama T, Stauch B, Ergasheva M, Romanovskaia D, Stepko A, Kovalev K, Shevtsov M, Gordeliy V, Han GW, Katritch V, Borshchevskiy V, Sarret P, Mishin A, Cherezov V.

Nat Commun. 2019 Dec 6;10(1):5573. doi: 10.1038/s41467-019-13348-2.

2.

Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs.

Luginina A, Gusach A, Marin E, Mishin A, Brouillette R, Popov P, Shiriaeva A, Besserer-Offroy É, Longpré JM, Lyapina E, Ishchenko A, Patel N, Polovinkin V, Safronova N, Bogorodskiy A, Edelweiss E, Hu H, Weierstall U, Liu W, Batyuk A, Gordeliy V, Han GW, Sarret P, Katritch V, Borshchevskiy V, Cherezov V.

Sci Adv. 2019 Oct 9;5(10):eaax2518. doi: 10.1126/sciadv.aax2518. eCollection 2019 Oct.

3.

An outlook on using serial femtosecond crystallography in drug discovery.

Mishin A, Gusach A, Luginina A, Marin E, Borshchevskiy V, Cherezov V.

Expert Opin Drug Discov. 2019 Sep;14(9):933-945. doi: 10.1080/17460441.2019.1626822. Epub 2019 Jun 11.

PMID:
31184514
4.

Expression and purification of an engineered human endothelin receptor B in a monomeric form.

Mishin AV, Luginina AP, Potapenko AP, Borshchevskiy VI, Katritch V, Edelweiss E, Okhrimenko IS, Gordeliy VI, Cherezov VG.

Dokl Biochem Biophys. 2016 Mar;467(1):157-61. doi: 10.1134/S1607672916020216. Epub 2016 May 20.

PMID:
27193723
5.

[Changes in the heterophile antibody titer in patients with cancer of the uterine cervix during radiation therapy].

Luginina AS, Nesyn IN, Zakler EI.

Vopr Onkol. 1969;15(1):37-40. Russian. No abstract available.

PMID:
5784516

Supplemental Content

Loading ...
Support Center